Skip to content

i-Stitch for Bilateral Sacrospinous Ligament Fixation (SSLF)

i-Stitch for Bilateral Sacrospinous Ligament Fixation (SSLF)

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06805006
Acronym
i-StitchSSLF
Enrollment
100
Registered
2025-02-03
Start date
2025-01-01
Completion date
2026-10-31
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital Prolapse, Pelvic Organ Prolapse

Keywords

bilateral sacrospinous ligament fixation, suture attachment medical device

Brief summary

The purpose of the clinical investigation is to generate clinical data to substantiate the safety and performance of the i-Stitch device for bilateral sacrospinous ligament fixation (SSLF) in pelvic organ prolapse (POP) repair.

Detailed description

The i-Stitch instrument is a reusable instrument for attaching sutures to tissue with or without surgical mesh implants in urogynaecology. It is used together with the i-Stitch loading units. The use of i-Stitch for the fixation of surgical urogynaecological mesh implants (e.g. BSC Mesh, InGYNious) has already been proven in several studies. The aim of the present retrospective study is to generate clinical data to show the safety and performance of the i-Stitch instrument in bilateral sacrospinous ligament fixation (SSLF) without the use of a surgical mesh.

Interventions

DEVICESSLF

Bilateral sacrospinous ligament fixation with i-Stitch device

Sponsors

A.M.I. Agency for Medical Innovations GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Surgery for POP * SSLF with usage of i-Stitch device (\& i-Stitch Loading Units) * Concomitant procedures are allowed * Women minimum 18 years old * Written informed consent for surgery

Exclusion criteria

* infection (active or latent) * allergies to the materials used * benign or malignant changes * anticoagulation disorders * autoimmune connective tissue disorders * any uterus pathologies

Design outcomes

Primary

MeasureTime frameDescription
Subjective outcome12 monthsGerman Pelvic Floor Questionnaire ("Deutscher Beckenboden-Fragebogen")

Secondary

MeasureTime frameDescription
Quality of life (ICIQ-UI SF)12 monthsurinary incontinence and its impact on quality of life using the short form of the International Consultation on Incontinence Questionnaire
Postoperative complications12 monthsComplications in women undergoing bilateral SSLF using the i-Stitch
Anatomical outcome (POP-Q)12 monthsObjective anatomical failure/recurrent prolapse in any anatomical compartment

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORUrsula Peschers, Prof. Dr.

ISAR Klinikum Munich

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026